July 11, 2025 – Our company is pleased to announce that we have officially signed a strategic cooperation agreement with Progenesis, USA. The two parties will carry out in-depth cooperation worldwide focusing on AI embryo analysis software and other cutting-edge products, jointly promoting the intelligent development of assisted reproductive technology (ART).
Progenesis is one of the leaders in in vitro fertilization (IVF) genetic testing in the United States and globally. With over 20 years of industry experience, the company serves more than 1,500 clinics worldwide and has helped over 100,000 families realize their dream of having children. Progenesis enjoys a prestigious reputation in the industry for its advanced preimplantation genetic testing (PGT) technologies and extensive global business network.
Under the agreement, Progenesis will leverage its extensive customer network in key markets such as the United States, Brazil, and India to promote Fertsy’s flagship product—EmbryoInsights™ AI Embryo Analysis Software. Furthermore, both parties will actively explore in-depth product-level integration and jointly conduct research cooperation on future-oriented “multimodal AI” embryo assessment technologies, aiming to provide more accurate and efficient fertility solutions for patients worldwide.
The cooperation with Progenesis marks a significant progress in Fertsy’s continued globalization strategy, further deepening our “local agency + global cooperation” dual-wing development model. Progenesis’ strong market coverage and industry credibility will provide robust support for our business expansion in key markets such as the Americas and South Asia, enabling our innovative technologies to serve a broader population.
Progenesis is among the many peers Fertsy met at the recently concluded ESHRE 2025 (European Society of Human Reproduction and Embryology 2025) that has taken the most agile and rapid action. In the coming weeks and months, more news about global cooperation initiatives and deal closures can be expected. All such collaborations and transactions will give full play to the respective advantages of all parties in technological R&D and market channels, jointly committed to improving IVF success rates, reducing the burden on patients, and leading the global assisted reproductive industry into a new AI-driven era.
About Fertsy
Fertsy is committed to using innovative technologies such as artificial intelligence to improve the success rate and accessibility of assisted reproduction, striving to become a comprehensive solution provider for the next generation of intelligent reproductive centers.
About Progenesis
Progenesis is a leading global genetic testing company founded in 2015 and headquartered in San Diego. It specializes in providing non-invasive genetic testing services for patients in family planning. The company offers a variety of customized services to meet the needs of different patients. Progenesis’ team consists of passionate genetic experts, researchers, and laboratory professionals, dedicated to improving patients’ lives. As a pioneer in genetic screening technology, Progenesis’ scientists continuously advance research to enhance services and deepen the understanding of human genetics. They recognize the trust patients place in them regarding the health of their future children and take this as their responsibility. All tests conducted by Progenesis adopt the latest, industry-leading molecular biology technologies to ensure the most accurate results. The team has optimized next-generation sequencing technologies for aneuploidy screening of all 24 chromosomes (PGT-A/PGT-SR/PGT-M) and provides 12-hour rapid testing to support fresh embryo transfer. Progenesis adheres to the highest quality control standards in its laboratories and is accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA#05D2121237). Its customer support team works closely with IVF clinics to ensure the secure and efficient sharing of patient information, committed to continuously providing high-quality services. The company has in-house genetic counselors available to provide consultation for patients at any time.